Effect of Neoagarooligosaccharide on overweight or Obese Adults

Effect of hydrolized Neo-agaro-oligosaccharide on the reduction of body weight and the improvement of blood lipids concentration in overweight or obese adults

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CRIS

Registry ID

KCT0009556

Enrollment

Registered

2024-06-21

Start date

2023-01-01

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : The research product used in this study was produced and provided by Dine Bio Inc. NAO was produced by hydrolyzing an agar solution, obtained by hot water extraction of Gelidium,

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Adult men and women aged 18-64 2) Individuals who are overweight or obese with a Body Mass Index (BMI) of 23 kg/m² or higher 3) Individuals who have not experienced a weight change of more than 10% in the past 6 months 4) Individuals who are able to consume the product for 12 weeks 5) Individuals who can participate in various tests at Kyung Hee University International Campus twice during the study period (week 0 and week 12) 6) Individuals who have no difficulty swallowing

Exclusion criteria

Exclusion criteria: 1) Individuals using obesity treatments or weight loss supplements 2) Individuals with mental disorders such as depression or dementia 3) Individuals following a diet aimed at weight loss 4) Individuals with type 1 diabetes 5) Individuals taking dietary fiber supplements 6) Individuals allergic to Gelidium 7) Women who are pregnant, breastfeeding, or planning to become pregnant 8) Individuals with excessive smoking habits or alcohol addiction 9) Individuals experiencing severe gastrointestinal symptoms such as heartburn, indigestion, or diarrhea 10) Individuals with acute or chronic illnesses or other health restrictions 11) Individuals deemed by the researcher to have difficulty participating in the study

Design outcomes

Primary

Measure	Time frame
anthropometric measurements (weight, body mass index, waist circumference, hip circumference, waist-to-hip ratio, muscle mass, body fat mass, body fat percentage, visceral fat area)	—

Secondary

Measure	Time frame
blood tests (total cholesterol, LDL cholesterol, HDL cholesterol, fasting blood glucose, CRP);bowel movements (CSS, PAC-SYM, PAC-QOL survey score);glucose AUC by 50g oral glucose tolerance test	—

Countries

Korea, Republic of

Contacts

Public ContactYeounhee Kim

Kyung Hee University Global Campus

younhee0378@naver.com+82-31-201-3818

Outcome results